188 related articles for article (PubMed ID: 29190165)
1. Challenging Treatment of Ocular Surface Squamous Neoplasia in Patients with Atopic Disease.
Zhang L; Mercado C; Galor A; Holland EJ; Wang G; Karp CL
Ocul Immunol Inflamm; 2019; 27(2):288-293. PubMed ID: 29190165
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
[TBL] [Abstract][Full Text] [Related]
3. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
Kusumesh R; Ambastha A; Sinha B; Kumar R
Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
[TBL] [Abstract][Full Text] [Related]
4. Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response.
Kaliki S; Bejjanki KM; Desai A; Mohamed A
Semin Ophthalmol; 2019; 34(7-8):465-472. PubMed ID: 31370766
[TBL] [Abstract][Full Text] [Related]
5. Long term study of topical interferon α-2b eye drops as primary treatment of ocular surface squamous neoplasia.
Sripawadkul W; Reyes-Capo D; Zein M; Wylegala A; Albayyat G; Galor A; Karp CL
Ocul Surf; 2023 Apr; 28():108-114. PubMed ID: 36592780
[TBL] [Abstract][Full Text] [Related]
6. Management of Ocular Surface Squamous Neoplasia with Topical and Intralesional Interferon Alpha 2B in Mexicans.
Nava-Castañeda Á; Hernández-Orgaz J; Garnica-Hayashi L; Ansart A; Matus G; Tovilla-Canales JL
Nepal J Ophthalmol; 2018 Jul; 10(20):143-150. PubMed ID: 31056557
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
Venkateswaran N; Mercado C; Galor A; Karp CL
Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
[TBL] [Abstract][Full Text] [Related]
8. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
Chaugule SS; Park J; Finger PT
Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes.
Bakal K; Molugu S; Machakuri K; Bejjanki KM; Kapoor AG; Kaliki S
Int Ophthalmol; 2024 Jun; 44(1):251. PubMed ID: 38907750
[TBL] [Abstract][Full Text] [Related]
10. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
Sturges A; Butt AL; Lai JE; Chodosh J
Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
[TBL] [Abstract][Full Text] [Related]
11. Changes in in vivo confocal microscopic findings of ocular surface squamous neoplasia during treatment with topical interferon alfa-2b.
Zarei-Ghanavati M; Mousavi E; Nabavi A; Latifi G; Mehrjardi HZ; Mohebbi M; Ghassemi H; Mirzaie F; Zare MA
Ocul Surf; 2018 Apr; 16(2):235-241. PubMed ID: 29306088
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, safety and cost-effectiveness of 5-fluorouracil versus interferon α-2b as adjuvant therapy after surgery in ocular surface squamous neoplasia in a southern European tertiary hospital.
San Román Llorens JJ; Fernández-Gurria M; Artaechevarria Artieda J; Alejandre Alba N; García Sandoval B; Jiménez-Alfaro Morote I
Int Ophthalmol; 2024 Apr; 44(1):184. PubMed ID: 38630143
[TBL] [Abstract][Full Text] [Related]
13. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.
Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL
Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578
[TBL] [Abstract][Full Text] [Related]
14. Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients.
Kaliki S; Singh S; Iram S; Tripuraneni D
Indian J Ophthalmol; 2016 Oct; 64(10):702-709. PubMed ID: 27905329
[TBL] [Abstract][Full Text] [Related]
15. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment.
Leventer I; Singh H; Pashaee B; Raimondo CD; Khakh CK; Martin JL; Acharya B; Zhang Q; Lally SE; Shields CL
Asia Pac J Ophthalmol (Phila); 2024; 13(2):100052. PubMed ID: 38521390
[TBL] [Abstract][Full Text] [Related]
16. Ocular surface squamous neoplasia in an immunosuppressed patient with atopic keratoconjunctivitis.
Flynn TH; Manzouri B; Tuft SJ
Int Ophthalmol; 2012 Oct; 32(5):471-3. PubMed ID: 22581322
[TBL] [Abstract][Full Text] [Related]
17. Primary treatment of ocular surface squamous neoplasia with topical interferon alpha-2b: Comparative analysis of outcomes based on original tumor configuration.
Shields CL; Constantinescu AB; Paulose SA; Yaghy A; Dalvin LA; Shields JA; Lally SE
Indian J Ophthalmol; 2021 Mar; 69(3):563-567. PubMed ID: 33595473
[TBL] [Abstract][Full Text] [Related]
18. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE
Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315
[TBL] [Abstract][Full Text] [Related]
19. Optical coherence tomography angiography in the evaluation of vascular patterns of ocular surface squamous neoplasia during topical medical treatment.
Theotoka D; Liu Z; Wall S; Galor A; Al Bayyat GJ; Feuer W; Jianhua W; Karp CL
Ocul Surf; 2022 Jul; 25():8-18. PubMed ID: 35358712
[TBL] [Abstract][Full Text] [Related]
20. Role of topical interferon alpha-2b in 'mitomycin-C-resistant' ocular surface squamous neoplasia: our preliminary findings.
Singh M; Gautam N; Kaur M
Int Ophthalmol; 2019 Feb; 39(2):295-301. PubMed ID: 29362973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
